Biogaia AB Sponsored ADR (BIOGY)
OTC PINK OTC PINK Primary Summary
BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call Transcript
BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call Transcript
Biogaia AB Sponsored ADR (BIOGY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Biogaia AB Sponsored ADR ever had a stock split?
Biogaia AB Sponsored ADR Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Theresa Agnew CEO | OTC PINK Exchange | 09072J102 CUSIP |
| SE Country | 242 Employees | 11 May 2026 Last Dividend | 26 May 2022 Last Split | - IPO Date |
Overview
BioGaia AB (publ) is a globally recognized healthcare company specializing in the development and distribution of probiotic products. Established in 1990, the company has its headquarters in Stockholm, Sweden. It operates through three primary segments: Pediatrics, Adult Health, and Other. BioGaia has carved a niche for itself in the healthcare industry by focusing on delivering probiotic products that cater to different age groups and health needs. Its distribution network spans worldwide, leveraging both external partners and proprietary channels to reach a diverse customer base.
Products and Services
- Pediatrics Segment:
Under its Pediatrics segment, BioGaia offers a range of probiotic products aimed at improving children's health. This includes probiotic drops, which are designed to be easy to administer to infants and young children; oral rehydration solutions, which provide essential electrolytes lost during bouts of diarrhea; gut health tablets tailored for slightly older children; and specific cultures used as ingredients in infant formulas. These products are developed to support the digestive systems of babies and children, enhancing overall health and wellbeing.
- Adult Health Segment:
The Adult Health segment focuses on products for grown-ups, including gut health tablets that help maintain a healthy digestive system; oral health lozenges designed to support the oral microbiome; and specific probiotic cultures used in a licensee's dairy products. These offerings target common adult health concerns, particularly those related to gut and oral health, providing natural, probiotic-based solutions.
- Other Segment:
Aside from its core probiotic products, BioGaia also engages in the provision of packaging solutions. This segment serves to support the company's main operations as well as offering these services to the wider market. It underscores BioGaia's commitment to delivering not just health solutions but also supporting the lifecycle of its products from production to consumer.
